Introduction
Development of perampanel in epilepsy
AMPA receptors as a molecular target in epilepsy therapy
Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist
Efficacy of perampanel: a review of clinical trial data
Safety and tolerability of perampanel: a review of clinical trial data
Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures